Xerox Phaser 6250 Guía De Referencia página 182

Additional Information: The results obtained from a Xerox sponsored Chronic Toner
Inhalation Study demonstrated no lung changes in rats for the lowest (1 mg/m
(i.e., the level most relevant to potential human exposure). A very slight degree of fibrosis was
noted in 25% of the animals at the middle (4 mg/m
fibrosis was noted in all the animals at the highest (16 mg/m
attributed to "lung overloading," a generic response to excessive amounts of any dust retained
in the lungs for a prolonged period. This study was conducted using a special test toner to
comply with EPA testing protocol. The test toner was ten times more respirable than
commercially available Xerox toner and would not be functionally suitable for Xerox
equipment.
Section 12–Ecological Information
Not available
Section 13–Disposal Consideration
These materials are not RCRA hazardous wastes as specified in 40 CFR 261. State and local
waste disposal requirements, however, may be more restrictive. Dispose in accordance with all
federal, state, and local regulations. Incinerate only in a closed container.
Section 14–Transport Information
DOT: Not regulated
Section 15–Regulatory Information
TSCA: All components of these toners have been manufactured in compliance with TSCA.
CANADIAN WHMIS: These toners are not regulated as controlled products under the
Workplace Hazardous Material Information System (WHMIS).
Section 16–Other Information
NFPA 704: Health–0, Fire–1, Reactivity–0 (All colors)
Original preparation date: 05/06/2003
Xerox Corporation
Office Group
Environmental, Health & Safety
P.O. Box 1000
Mail Stop 60-512
Wilsonville, Oregon 97070
Safety Information: 800-828-6571
Health Emergency: 585-422-2177
Transportation Emergency (Chemtrec): 800-424-9300
3
Impresora láser a color Phaser® 6250
E-5
) exposure level, while a slight degree of
3
) exposure level. The findings are
3
) exposure level